Last week, Drew Schiller, CEO, Validic, joined Dr. Sam Volchenboum, director, Center for Research Informatics, University of Chicago, on the Litmust Health podcast Trial by Data to discuss the path to novel endpoints and the role of data standards in clinical trials.
With new information available from wearables, apps, and in-home health devices, patient-generated health data offers an opportunity for deeper insights within clinical trials. Though many leaders may be hesitant to introduce new data points, the incorporation of this information into trials surrounding the most relevant use cases, and the development of proper data standards, can inform more meaningful insights within trials. And, buy-in from the right stakeholders can make from a more efficient path toward the integration of these novel endpoints. Read more insights from the podcast here, or listen above.